small molecule

DEXAMETHASONE

DEXAMETHASONE

Loss of exclusivityloss of exclusivity
CompanyKEY THERAPEUTICS LLC

Drug detail

Brand nameDEXAMETHASONE
Active ingredientDEXAMETHASONE
Strength1.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 1983
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DEXAMETHASONE patent cliff — loss of exclusivity — | CliffBio